Anton C, Trifan A, Stanciu C, Stanciu G O, Malgarinos G
Faculté de Medicine, 2-éme Clinique Medicale Gastroenterologie, Université de Medicine et Pharmacie Gr. T. Popa.
Rev Med Chir Soc Med Nat Iasi. 2000 Apr-Jun;104(2):135-7.
Interferon alpha (IFN-alpha) is a well-established first-line treatment for chronic viral hepatitis. Side effects of IFN-alpha therapy are common but generally mild and self-limited. Generalized seizures during IFN-alpha therapy are very uncommon and are present in clinical isolated cases and usually in association with high doses of IFN-alpha. In our case a female of 39 years old, seizures have occurred at low doses of IFN-alpha used as therapy for chronic C viral hepatitis. As it comes to our knowledge, till now, there were published only 4 cases of generalized seizures that occurred during treatment with IFN-alpha for chronic C viral hepatitis. The physiopathology of this complication is unknown. Generalized seizures can be reasonable due to IFN-alpha therapy, as long as the patient didn't have any seizure history, or other factors, which can develop seizures. Neurological examination, EEG and brain scan were normal. The recurrence of these seizures was absent stopping IFN-alpha therapy without any other seizure treatment.
干扰素α(IFN-α)是慢性病毒性肝炎公认的一线治疗药物。IFN-α治疗的副作用很常见,但一般较轻且为自限性。IFN-α治疗期间全身性癫痫发作非常罕见,仅见于临床个别病例,通常与高剂量IFN-α有关。在我们的病例中,一名39岁女性在使用低剂量IFN-α治疗慢性丙型病毒性肝炎时发生了癫痫发作。据我们所知,迄今为止,仅发表了4例在使用IFN-α治疗慢性丙型病毒性肝炎期间发生全身性癫痫发作的病例。这种并发症的病理生理学尚不清楚。只要患者没有癫痫病史或其他可引发癫痫的因素,全身性癫痫发作可能与IFN-α治疗有关。神经学检查、脑电图和脑部扫描均正常。停用IFN-α治疗且未进行任何其他癫痫治疗后,癫痫未复发。